SCHEMBL24626209

SCHEMBL24626209

c1ccc(-c2cc(-c3ccccn3)nc(-c3cc(-c4ccccc4-c4cccc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)c4)ccn3)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.44
▸ SMN1; SMN2 Q16637 4/20 0.44
▸ CCR1 P32246 3/20 0.44
▸ CCR5 P51681 3/20 0.44
▸ CCR8 P51685 3/20 0.44
▸ TP53 P04637 3/20 0.44
▸ LMNA P02545 3/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44
▸ ALPL P05186 1/20 0.44
▸ HSP90AA1 P07900 1/20 0.44
▸ ALPI P09923 1/20 0.44
▸ ALPG P10696 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ TGFBR1 P36897 5/20 0.43
▸ GRM5 P41594 2/20 0.43
▸ PIK3CA P42336 1/20 0.41
▸ PIK3CB P42338 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24627025 0.95 GRM5 (0.44) KDM4ESMN1; SMN2CCR1CCR5CCR8
SCHEMBL24626554 0.94 TGFBR1 (0.45) KDM4ESMN1; SMN2CCR1CCR5CCR8
SCHEMBL24626542 0.93 KDM4E (0.45) KDM4ESMN1; SMN2CCR1CCR5CCR8
SCHEMBL24626457 0.93 TGFBR1 (0.44) KDM4ESMN1; SMN2CCR1CCR5CCR8
SCHEMBL23081866 0.93 KDM4E (0.47) KDM4ESMN1; SMN2CCR1CCR5CCR8
SCHEMBL24626545 0.93 KDM4E (0.47) KDM4ESMN1; SMN2CCR1CCR5CCR8
SCHEMBL23081819 0.92 TGFBR1 (0.44) KDM4ESMN1; SMN2CCR1CCR5CCR8
SCHEMBL23081963 0.92 KDM4E (0.44) KDM4ESMN1; SMN2CCR1CCR5CCR8
SCHEMBL23081839 0.92 KDM4E (0.46) KDM4ESMN1; SMN2CCR1CCR5CCR8
SCHEMBL24626687 0.92 KDM4E (0.49) KDM4ESMN1; SMN2CCR1CCR5CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220223795-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2022-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220223795-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 KDM4E 2496/4885SMN1; SMN2 3932/4885CCR1 1810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback